MedPath

Lin Nancy MD

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:1
Completed:2

Trial Phases

2 Phases

Phase 1:1
Phase 2:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 2
3 (75.0%)
Phase 1
1 (25.0%)

Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC

Phase 2
Active, not recruiting
Conditions
Central Nervous System Metastases
HER2-positive Metastatic Breast Cancer
Interventions
First Posted Date
2018-01-31
Last Posted Date
2025-04-02
Lead Sponsor
Nancy Lin, MD
Target Recruit Count
19
Registration Number
NCT03417544
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases

Phase 2
Terminated
Conditions
Breast Cancer
CNS Disease
Interventions
First Posted Date
2007-07-04
Last Posted Date
2013-03-14
Lead Sponsor
Nancy Lin, MD
Target Recruit Count
15
Registration Number
NCT00496379
Locations
🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
Brain Metastases
Interventions
Procedure: Whole Brain Radiation
First Posted Date
2007-05-08
Last Posted Date
2014-05-22
Lead Sponsor
Nancy Lin, MD
Target Recruit Count
35
Registration Number
NCT00470847
Locations
🇺🇸

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States

🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2007-05-08
Last Posted Date
2024-12-19
Lead Sponsor
Nancy Lin, MD
Target Recruit Count
87
Registration Number
NCT00470704
Locations
🇺🇸

University fo Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

University of Chicago, Chicago, Illinois, United States

🇺🇸

Dana-Farber at Faulkner Hospital, Boston, Massachusetts, United States

and more 6 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.